Late diagnosis of HIV infection at two academic medical centers: 1994-2004

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 20, Issue 8, 2008, Pages 977-983

  Jean Jacques, M ^a   Walensky, R P ^b,c,d   Aaronson, W H ^b   Chang, Y ^b   Freedberg, K A ^b,d  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

HIV infections diagnosis; HIV infections epidemiology; HIV infections testing

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; FEMALE; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL;

ACADEMIC MEDICAL CENTERS; ADULT; AIDS SERODIAGNOSIS; BOSTON; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; STATISTICS AS TOPIC; TIME FACTORS;

EID: 51349129152     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120701767257     Document Type: Article

References (32)

1. Branson, B.M., Handsfield, H.H., Lampe, M.A., Janssen, R.S., Taylor, A.W., Lyss, S.B., et al. (2006). Revised recommendations for HIV testing of adults, adolescents and pregnant women in healthcare settings. Morbidity and Mortality Weekly Report Recommendations and Reports, 55, 1-17.
2. Centers for Disease Control and Prevention (CDC). (1992). Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report Recommendations and Reports, 41(RR-17), 1-19.
3. CDC. (1993). Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. Morbidity and Mortality Weekly Report Recommendations and Reports, 42, 1-6.
4. CDC. (2003). Advancing HIV prevention: New strategies for a changing epidemic - United States, 2003. Morbidity and Mortality Weekly Report Recommendations and Reports, 52, 329-332.
5. Crum, N.F., Riffenburgh, R.H., Wegner, S., Agan, B.K., Tasker, S.A., Spooner, K.M., et al. (2006). Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early and late HAART eras. Journal of Acquired Immune Deficiency Syndromes, 41, 194-200.
6. Dybul, M., Bolan, R., Condoluci, D., Cox-Iyamu, R., Redfield, R., Hallahan, C.W., et al. (2002). Evaluation of initial CD4+T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. Journal of Infectious Diseases, 185, 1818-1821.
7. Fleming, P.L., Wortley, P.M., Karon, J.M., DeCock, K.M., & Janssen, R.S. (2000). Tracking the HIV epidemic: Current issues, future challenges. American Journal of Public Health, 90, 1037-1041.
8. Hightow, L., MacDonald, P., & Boland, M. (2005, February). Missed opportunities for the diagnosis of acute HIV infection: room for improvement. Paper presented at the 12th Conference on Retroviruses and Opportunistic Infections, Boston, MA.
9. Katz, M.H., Bindman, A.B., Keane, D., & Chan, A.K. (1992). CD4 lymphocyte count as an indicator of delay in seeking human immunodeficiency virus-related treatment. Archives of Internal Medicine, 152, 1501-1504.
10. Klein, D., Hurley, L.B., Merrill, D., & Quesenberry, C.P., Jr. (2003). Review of medical encounters in the five years before a diagnosis of HIV-1 infection: Implications for early detection. Journal of Acquired Immune Deficiency Syndromes, 32, 143-152.
11. Liddicoat, R.V., Horton, N.J., Urban, R., Maier, E., Christiansen, D., & Samet, J.H. (2004). Assessing missed opportunities for HIV testing in medical settings. Journal of General Internal Medicine, 19, 349-356.
12. Lifson, A.R., & Rybicki, S.L. (2007). Routine opt-out HIV testing. Lancet, 369, 539-540.
13. Louis, C., Ivers, L.C., Fawzi, M.C., Freedberg, K.A., & Castro, A. (2007). Late presentation for HIV care in central Haiti: Factors limiting access to care. AIDS Care, 19, 487-491.
14. Loupa, C.V., Lederman, M.M., Valdez, H., Salata, R.A., McComsey, G.A., Gripshover, B., et al. (2005). New entrants to HIV care are presenting only at marginally earlier stages of disease but may increasingly represent groups perceived at lower risk. Journal of the International Association Physicians in AIDS Care, 4, 47-51.
15. Lubelchek, R., Kroc, K., Hota, B., Sharief, R., Muppudi, U., Pulvirenti, J., et al. (2005). The role of rapid versus conventional human immunodeficiency virus testing for inpatients: Effects on quality of care. Archives of Internal Medicine, 165, 1956-1960.
16. Manfredi, R., Calza, L., & Chiodo, F. (2001). Lack of change in the distribution of AIDS-defining opportunistic diseases and the related degree of immunodeficiency during the periods before and after the introduction of highly active antiretroviral therapy. European Journal of Clinical Microbiology and Infectious Diseases, 20, 410-413.
17. Palella, F.J., Jr.,, Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338, 853-860.
18. Paltiel, A.D., Walensky, R.P., Schackman, B.R., Seage, G.R., 3rd,, Mercincavage, L.M., Weinstein, M.C., et al. (2006). Expanded HIV screening in the United States: Effect on clinical outcomes, HIV transmission and costs. Annals of Internal Medicine, 145, 797-806.
19. Paltiel, A.D., Weinstein, M.C., Kimmel, A.D., Seage, G.R., 3rd,, Losina, E., Zhang, H., et al. (2005). Expanded screening for HIV in the United States: An analysis of cost-effectiveness. New England Journal of Medicine, 352, 586-595.
20. Partners Research Computing RPDR Web Page. (2007). Retrieved May 16, 2007, from http://www.partners.org/rescomputing/template.asp?pageid= 64&ArticleTitle=RPDR&subPage=true&level1ID=9&tocId= 9&articleSubPage=true
21. Sackoff, J.E., & Shin, S.S. (2001). Trends in immunologic and clinical status of newly diagnosed HIV-positive patients initiating care in the HAART era. Journal of Acquired Immune Deficiency Syndromes, 28, 270-272.
22. Samet, J.H., Freedberg, K.A., Savetsky, J.B., Sullivan, L.M., & Stein, M.D. (2001). Understanding delay to medical care for HIV infection: The long-term nonpresenter. AIDS, 15, 77-85.
23. Samet, J.H., Freedberg, K.A., Stein, M.D., Lewis, R., Savetsky, J., Sullivan, L., et al. (1998). Trillion virion delay: Time from testing positive for HIV to presentation for primary care. Archives of Internal Medicine, 158, 734-740.
24. Sanders, G.D., Bayoumi, A.M., Sundaram, V., Bilir, S.P., Neukermans, C.P., Rydzak, C.E., et al. (2005). Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. New England Journal of Medicine, 352, 570-585.
25. USPHS/IDSA Prevention of Opportunistic Infections Working Group. (1995). USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: Disease-specific recommendations. Clinical Infectious Diseases, 21, S32-S43.
26. USPHS/IDSA Prevention of Opportunistic Infections Working Group. (1997). USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: Disease-specific recommendations. Clinical Infectious Diseases, 25, S313-S335.
27. USPHS/IDSA Prevention of Opportunistic Infections Working Group. (1999). USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Clinical Infectious Diseases, 30, S29-S65.
28. USPHS/IDSA Prevention of Opportunistic Infections Working Group. (2002). USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Infectious Diseases in Obstetrics and Gynecology, 10, 3-64.
29. Walensky, R.P., Losina, E., Malatesta, L., Barton, G.E., O'Connor, C.A., Skolnik, P.R., et al. (2005). Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. American Journal of Public Health, 95, 71-73.
30. Walensky, R.P., Losina, E., Steger-Craven, K.A., & Freedberg, K.A. (2002). Identifying undiagnosed human immunodeficiency virus: The yield of routine, voluntary inpatient testing. Archives of Internal Medicine, 162, 887-892.
31. Walensky, R.P., Paltiel, A.D., Losina, E., Mercincavage, L.M., Schackman, B.R., Sax, P.E., et al. (2006). The survival benefits of AIDS treatment in the United States. Journal of Infectious Diseases, 194, 11-19.
32. Walensky, R.P., Weinstein, M.C., Kimmel, A.D., Seage, G.R., 3rd,, Losina, E., Sax, P.E., et al. (2005). Routine human immunodeficiency virus testing: An economic evaluation of current guidelines. American Journal of Medicine, 118, 292-300.